For the quarter ending 2026-03-31, TRAW has $8,156K in assets. $13,467K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,133 | 3,820 | 6,420 | 13,081 |
| Tax incentive and other receivables | 1,687 | 3,794 | 1,991 | 1,323 |
| Prepaid expenses and other assets | 845 | 365 | 1,214 | 966 |
| Total current assets | 5,665 | 7,979 | 9,625 | 15,370 |
| Property and equipment, net | 6 | 7 | 7 | 8 |
| Intangible assets, net | 2,484 | 2,527 | 2,571 | - |
| Other assets | 1 | 104 | 240 | 244 |
| Total assets | 8,156 | 10,617 | 12,443 | 15,622 |
| Accounts payable | 7,665 | 5,653 | 5,105 | 4,759 |
| Accrued expenses and other liabilities | 5,543 | 5,493 | 2,782 | 2,593 |
| Total current liabilities | 13,208 | 11,146 | 7,887 | 7,352 |
| Warrant liabilities | 259 | 100 | 11 | 8 |
| Total liabilities | 13,467 | 11,246 | 7,898 | 7,360 |
| Common stock, 0.01 par value, 250,000,000 shares authorized, 10,162,587 and 9,067,774 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 101 | 90 | 71 | 71 |
| Additional paid-in capital | 641,681 | 639,259 | 637,009 | 636,761 |
| Accumulated deficit | -647,091 | -639,984 | -632,541 | -628,579 |
| Accumulated other comprehensive (loss) income | -2 | 6 | 6 | 9 |
| Total stockholders' deficit | -5,311 | -629 | 4,545 | 8,262 |
| Total liabilities and stockholders' deficit | 8,156 | 10,617 | 12,443 | 15,622 |
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW)